首页> 外文期刊>BMC Public Health >Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality
【24h】

Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality

机译:拯救生命的工具在妊娠期间梅毒的补充检测和治疗,以减少梅毒相关的死产和新生儿死亡率

获取原文
           

摘要

Background Globally syphilis is an important yet preventable cause of stillbirth, neonatal mortality and morbidity.Objectives This review sought to estimate the effect of detection and treatment of active syphilis in pregnancy with at least 2.4MU benzathine penicillin (or equivalent) on syphilis-related stillbirths and neonatal mortality. Methods We conducted a systematic literature review of multiple databases to identify relevant studies. Data were abstracted into standardised tables and the quality of evidence was assessed using adapted GRADE criteria. Where appropriate, meta-analyses were undertaken. Results Moderate quality evidence (3 studies) supports a reduction in the incidence of clinical congenital syphilis of 97% (95% c.i 93 – 98%) with detection and treatment of women with active syphilis in pregnancy with at least 2.4MU penicillin. The results of meta-analyses suggest that treatment with penicillin is associated with an 82% reduction in stillbirth (95% c.i. 67 – 90%) (8 studies), a 64% reduction in preterm delivery (95% c.i. 53 – 73%) (7 studies) and an 80% reduction in neonatal deaths (95% c.i. 68 – 87%) (5 studies). Although these effect estimates were large and remarkably consistent across studies, few of the studies adjusted for potential confounding factors and thus the overall quality of the evidence was considered low. However, given these large observed effects and a clear biological mechanism for effectiveness the GRADE recommendation is strong. Conclusion Detection and appropriate, timely penicillin treatment is a highly effective intervention to reduce adverse syphilis-related pregnancy outcomes. More research is required to identify the most cost-effective strategies for achieving maximum coverage of screening for all pregnant women, and access to treatment if required.
机译:背景技术全球性梅毒是死产,新生儿死亡率和发病率的重要但可预防的原因。目的本评价旨在评估妊娠期梅毒的检测和治疗对梅毒相关死产的影响,该梅毒至少使用2.4MU苄星青霉素(或同等水平)进行治疗。和新生儿死亡率。方法我们对多个数据库进行了系统的文献综述,以鉴定相关研究。将数据提取到标准化表中,并使用适应的GRADE标准评估证据的质量。在适当的情况下,进行荟萃分析。结果中等质量的证据(3项研究)支持检测和治疗孕妇中至少患有2.4MU青霉素的活动性梅毒,可将临床先天性梅毒的发生率降低97%(95%c.i 93 – 98%)。荟萃分析的结果表明,用青霉素治疗可使死胎减少82%(95%ci 67 – 90%)(8个研究),使早产减少64%(95%ci 53–73%)。 (7项研究),新生儿死亡率降低80%(95%ci 68 – 87%)(5项研究)。尽管这些影响估计值很大,并且在各个研究中都非常一致,但很少有研究针对潜在的混杂因素进行了调整,因此,证据的总体质量被认为很低。但是,鉴于这些观察到的巨大影响和明确的生物学机制,GRADE的建议是强有力的。结论检测和适当,及时的青霉素治疗是减少不良梅毒相关妊娠结局的有效干预措施。需要更多的研究来确定最具成本效益的策略,以最大程度地覆盖所有孕妇,并在需要时获得治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号